Linear IgA Bullous Dermatosis: Clinical Trials

2 trials for Linear IgA Bullous Dermatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Linear IgA Bullous Dermatosis: new trials by email Literature Review of Linear IgA Bullous Dermatosis trials Research Report on Linear IgA Bullous Dermatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Collection of biological samples - Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue, Pyoderma Gangrenosum
UnknownUniversity of Zurich6002014-01-012016-09-27
Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration
Dapsone single dose, Dapsone multiple dose, leucocytes - Methemoglobinemia, Linear IgA Bullous Dermatosis
Phase 1CompletedUniversity Medicine Greifswald232011-09-012015-07-09

Narrower conditions

Acute Generalized Exanthematous Pustulosis (1)  ·  Arthritis, Juvenile (1)  ·  Behcet Syndrome (1)  ·  Dermatitis Herpetiformis (1)  ·  Erythema elevatum diutinum (1)  ·  Hidradenitis (1)  ·  Keratosis (1)  ·  Methemoglobinemia (1)  ·  Pyoderma Gangrenosum (1)  ·  Skin Diseases, Vesiculobullous (1)  ·  Sweet Syndrome (1)

Broader conditions

Autoimmune Diseases (2)  ·  Immune System Diseases (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Arthritis (1)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Dermatitis (1)  ·  Drug Eruptions (1)  ·  Drug Hypersensitivity (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Erythema (1)  ·  Eye Diseases (1)

Interventions

Dapsone (1)  ·  Leukocyte Count (1)

Sponsors

University Medicine Greifswald (1)  ·  University of Zurich (1)

Countries

Germany (1)  ·  Switzerland (1)

Top investigators

Alexander Navarini, MD (1)  ·  Werner Siegmund, Prof (1)